Factors associated with the outcome of transforaminal epidural steroid injections
- Author(s)
- Tae Kyu Park; Ji Hee Hong; Jin Mo Kim; Jeong In Bae; Ae Ra Kim; Han-Min Lee; Yong-Cheol Lee
- Keimyung Author(s)
- Hong, Ji Hee; Kim, Jin Mo; Bae, Jung In; Kim, Ae Ra; Lee, Yong Cheol
- Department
- Dept. of Anesthesiology & Pain Medicine (마취통증의학)
- Journal Title
- Korean Journal of Anesthesiology
- Issued Date
- 2008
- Volume
- 55
- Issue
- 3
- Abstract
- Background: This study was undertaken to assaythe effectiveness of transforaminal epidural steroid injections (TFESIs) for
sciatica and to identify potential predictors related to treatment outcome.
Methods: TFESIs were performed in 150 patients between August 2006 and March 2007. Seventy-five patients (35 women,
40 men; mean age, 59.1 years), who met the inclusion criteria, were studied. Therapeutic effects were evaluated twoweeks after
injection. The following potential outcome predictors analyzed were as follows: one level vs. two level injection, Beck depression
inventory score (<13, 14−19, >20), Beck anxiety inventory score (<7, 8−15, >16), cause of radiculopathy (spinal stenosis
vs. herniated disk), gender, duration of radiculopathy (<6 months, 6−12 months, >6 months), and Oswestry disability index
score (<30, 31−60, >60). The relationships between possible outcome predictors and therapeutic effects were evaluated.
Results: Forty-nine of the 75 patients (65.3%) had a satisfactory result two weeks after TFESIs. Of these, twenty-four of
the 46 patients (52.2%) were treated by a one level injection and 25 (89.3%) of the 29 patients were treated by a two level
injection. This outcome was statistically significant (P < 0.01). None of the other potential outcome predictors showed any
statistical difference.
Conclusions: TFESI is recommended as an effective method of managing radiculopathy. Two-level injectionsmay result in
a better outcome than a one-level injection. (Korean J Anesthesiol 2008; 55: 298~304)
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.